Priya Sachdeva
Stock Analyst at UBS
(3.74)
# 2,025
Out of 5,023 analysts
14
Total ratings
90%
Success rate
27.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Priya Sachdeva
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Rated: Buy | $50 | $55.14 | -9.32% | 1 | Jul 28, 2026 | |
| MDT Medtronic | Rated: Hold | $90 → $85 | $86.38 | -1.60% | 2 | Jun 4, 2026 | |
| PEN Penumbra | Downgraded: Hold | $335 → $374 | $317.55 | +17.78% | 7 | Jan 20, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $18 → $22 | $12.70 | +73.23% | 4 | Dec 16, 2025 |
AtriCure
Jul 28, 2026
Rated: Buy
Price Target: $50
Current: $55.14
Upside: -9.32%
Medtronic
Jun 4, 2026
Rated: Hold
Price Target: $90 → $85
Current: $86.38
Upside: -1.60%
Penumbra
Jan 20, 2026
Downgraded: Hold
Price Target: $335 → $374
Current: $317.55
Upside: +17.78%
NeuroPace
Dec 16, 2025
Reiterated: Buy
Price Target: $18 → $22
Current: $12.70
Upside: +73.23%